Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families

被引:40
|
作者
Durocher, Francine [1 ]
Labrie, Yvan
Soucy, Penny
Sinilnikova, Olga
Labuda, Damian
Bessette, Paul
Chiquette, Jocelyne
Laframboise, Rachel
Lepine, Jean
Lesperance, Bernard
Ouellette, Genevieve
Pichette, Roxane
Plante, Marie
Tavtigian, Sean V.
Simard, Jacques
机构
[1] Ctr Hosp Univ Quebec, Oncol & Mol Endocrinol Res Ctr, Canc Genom Lab, Quebec City, PQ G1V 4G2, Canada
[2] Univ Laval, Quebec City, PQ G1V 4G2, Canada
[3] Hospices Civils Lyon, Ctr Leon Berard, Unite Mixte Genet Constitutionnelle Canc Frequent, Lyon, France
[4] Hop St Justine, Ctr Cancerol Charles Bruneau, Montreal, PQ H3T 1C5, Canada
[5] Hop St Sacrement, Clin Malad Sein Deschenes Fabia, Quebec City, PQ G1S 4L8, Canada
[6] CHUQ, Serv Med Genet, Quebec City, PQ G1V 4G2, Canada
[7] Ctr Hosp Reg Rimouski, Rimouski, PQ G5L 5T1, Canada
[8] Hop Sacre Coeur, Serv Hematooncol, Montreal, PQ H4J 1C5, Canada
[9] Hop Hotel Dieu, CHUQ, Gynecol Serv, Quebec City, PQ G1R 2J6, Canada
[10] WHO, Int Agcy Res Canc, Unit Genet Canc Susceptibil, Lyon, France
[11] Univ Laval, Dept Anat & Physiol, Canada Res Chair Oncogenet, Quebec City, PQ, Canada
关键词
D O I
10.1186/1471-2407-6-230
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Ataxia telangiectasia-mutated and Rad3-related (ATR) is a member of the PIK-related family which plays, along with ATM, a central role in cell-cycle regulation. ATR has been shown to phosphorylate several tumor suppressors like BRCA1, CHEK1 and TP53. ATR appears as a good candidate breast cancer susceptibility gene and the current study was designed to screen for ATR germline mutations potentially involved in breast cancer predisposition. Methods: ATR direct sequencing was performed using a fluorescent method while widely available programs were used for linkage disequilibrium (LD), haplotype analyses, and tagging SNP (tSNP) identification. Expression analyses were carried out using real-time PCR. Results: The complete sequence of all exons and flanking intronic sequences were analyzed in DNA samples from 54 individuals affected with breast cancer from non-BRCA1/2 high-risk French Canadian breast/ovarian families. Although no germline mutation has been identified in the coding region, we identified 41 sequence variants, including 16 coding variants, 3 of which are not reported in public databases. SNP haplotypes were established and tSNPs were identified in 73 healthy unrelated French Canadians, providing a valuable tool for further association studies involving the ATR gene, using large cohorts. Our analyses led to the identification of two novel alternative splice transcripts. In contrast to the transcript generated by an alternative splicing site in the intron 41, the one resulting from a deletion of 121 nucleotides in exon 33 is widely expressed, at significant but relatively low levels, in both normal and tumoral cells including normal breast and ovarian tissue. Conclusion: Although no deleterious mutations were identified in the ATR gene, the current study provides an haplotype analysis of the ATR gene polymorphisms, which allowed the identification of a set of SNPs that could be used as tSNPs for large-scale association studies. In addition, our study led to the characterization of a novel. 33 splice form, which could generate a putative truncated protein lacking several functional domains. Additional studies in large cohorts and other populations will be needed to further evaluate if common and/or rare ATR sequence variants can be associated with a modest or intermediate breast cancer risk.
引用
收藏
页数:21
相关论文
共 50 条
  • [31] Analysis of RAD51C Germline Mutations in High-Risk Breast and Ovarian Cancer Families and Ovarian Cancer Patients
    Thompson, Ella R.
    Boyle, Samantha E.
    Johnson, Julie
    Ryland, Georgina L.
    Sawyer, Sarah
    Choong, David Y. H.
    Chenevix-Trench, Georgia
    Trainer, Alison H.
    Lindeman, Geoffrey J.
    Mitchell, Gillian
    James, Paul A.
    Campbell, Ian G.
    HUMAN MUTATION, 2012, 33 (01) : 95 - 99
  • [32] LINKAGE ANALYSIS OF DUTCH FAMILIES AT HIGH-RISK FOR BREAST-CANCER
    WILSON, AF
    BAILEYWILSON, JE
    CLETON, FJ
    ELSTON, RC
    KING, MC
    GENETIC EPIDEMIOLOGY, 1986, : 87 - 92
  • [33] Tumor sequencing is useful to refine the analysis of germline variants in unexplained high-risk breast cancer families
    Cédric Van Marcke
    Raphaël Helaers
    Anne De Leener
    Ahmad Merhi
    Céline A. Schoonjans
    Jérôme Ambroise
    Christine Galant
    Paul Delrée
    Françoise Rothé
    Isabelle Bar
    Elsa Khoury
    Pascal Brouillard
    Jean-Luc Canon
    Peter Vuylsteke
    Jean-Pascal Machiels
    Martine Berlière
    Nisha Limaye
    Miikka Vikkula
    François P. Duhoux
    Breast Cancer Research, 22
  • [34] Tumor sequencing is useful to refine the analysis of germline variants in unexplained high-risk breast cancer families
    Van Marcke, Cedric
    Helaers, Raphael
    De Leener, Anne
    Merhi, Ahmad
    Schoonjans, Celine A.
    Ambroise, Jerome
    Galant, Christine
    Delree, Paul
    Rothe, Francoise
    Bar, Isabelle
    Khoury, Elsa
    Brouillard, Pascal
    Canon, Jean-Luc
    Vuylsteke, Peter
    Machiels, Jean-Pascal
    Berliere, Martine
    Limaye, Nisha
    Vikkula, Miikka
    Duhoux, Francois P.
    BREAST CANCER RESEARCH, 2020, 22 (01)
  • [35] Germline mutations in the breast cancer susceptibility gene PTEN are rare in high-risk non-BRCA1/2 French Canadian breast cancer families
    Guenard, Frederic
    Labrie, Yvan
    Ouellette, Genevieve
    Beauparlant, Charles Joly
    Bessette, Paul
    Chiquette, Jocelyne
    Laframboise, Rachel
    Lepine, Jean
    Lesperance, Bernard
    Pichette, Roxane
    Plante, Marie
    Durocher, Francise
    FAMILIAL CANCER, 2007, 6 (04) : 483 - 490
  • [36] Germline mutations in the breast cancer susceptibility gene PTEN are rare in high-risk non-BRCA1/2 French Canadian breast cancer families
    Frédéric Guénard
    Yvan Labrie
    Geneviève Ouellette
    Charles Joly Beauparlant
    Paul Bessette
    Jocelyne Chiquette
    Rachel Laframboise
    Jean Lépine
    Bernard Lespérance
    Roxane Pichette
    Marie Plante
    Francine Durocher
    Familial Cancer, 2007, 6 : 483 - 490
  • [37] BRCA1 mutation analysis in 27 cypriot families with high risk of hereditary breast and ovarian cancer
    Hadjisavvas, A
    Adamou, A
    Kyriacou, KC
    Christodoulou, C
    DISEASE MARKERS, 1999, 15 (1-3) : 98 - 98
  • [38] BRCA1mutation analysis in breast and ovarian cancer families from Greece
    I Konstantopoulou
    C Croupis
    A Ladopoulou
    A Pantazidis
    E Lianidou
    K Venetsanou
    E Efstathiou
    M Petersen
    J Janinis
    G Fountzilas
    E Chiotellis
    D Yannoukakos
    Breast Cancer Research, 2 (Suppl 1)
  • [39] BRCA1 Mutation Analysis in Breast/Ovarian Cancer Families from Greece
    Konstantopoulou, Irene
    Kroupis, Christos
    Ladopoulou, Angela
    Pantazidis, Alexandros
    Boumba, Dimitra
    Lianidou, Evriklia S.
    Petersen, Michael B.
    Florentin, Lina
    Chiotellis, Efstratios
    Nounesis, George
    Efstathiou, Eleni
    Skarlos, Dimosthenis
    Tsionou, Christina
    Fountzilas, George
    Yannoukakos, Drakoulis
    HUMAN MUTATION, 2000, 16 (03) : 272 - 273
  • [40] Tumor sequencing is useful to reclassify germline variants in unexplained high-risk breast cancer families
    Van Marcke, Cedric
    Helaers, Raphael
    Schoonjans, Celine A.
    Berliere, Martine
    De Leener, Anne
    Canon, Jean-Luc
    Vuylsteke, Peter
    Machiels, Jean-Pascal
    Limaye, Nisha
    Vikkula, Miikka
    Duhoux, Francois P.
    CANCER RESEARCH, 2020, 80 (04)